News
Land of opportunity Since AstraZeneca has quite a presence in the U.S. healthcare market and does much of its business in the country, it makes abundant sense to shift the main stock market ...
Fresh concerns have emerged about the platelet studies underpinning the FDA approval of ticagrelor, AstraZeneca's multibillion-dollar heart drug. A new BMJ investigation reveals data ...
AstraZeneca PLC AZN shares rallied 2.79% to £104.02 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,785.33 ...
Pressure is piling on London's stock exchange, with reports that British pharma giant AstraZeneca may move its listing to the U.S. delivering yet another blow this week. CEO Pascal Soriot is ...
AstraZeneca has started the process to improve its cancer treatment capabilities with an addition to its campus in southwest Frederick.
Natasha Sarin, President & Co-Founder of the Budget Lab at Yale University, talks about how the current Tax Bill will benefit the wealthy, add to the US deficit, and states that over the long run ...
That morning, U.K. newspaper The Times published an article stating that AstraZeneca CEO Pascal Soriot aims to move the company's stock market listing onto our shores (ADSes are certificates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results